Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALT-HF
NCT07596329Phase 3Not yet recruiting
- Sponsor
- Université de Monastir
- Start
- Sep 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules, Device-based Delivery
01
Overview
A Phase 3 trial of hypertonic saline in cardiorenal syndrome (CRS), sponsored by Université de Monastir. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
hypertonic saline
03
Conditions
cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT07596329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07596329.